PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) HETERODIMERS REDUCE SERUM LDL-CHOLESTEROL (LDL-C) LEVELS IN MAINTENANCE HEMODIALYSIS (HD) PATIENTS ASSOCIATED WITH DYSLIPIDEMIA CHARACTERIZED BY INCREASED TRIGLYCERIDE-RICH LIPOPROTEINS

被引：0
|
作者：
Kihara, Emi [1 ]
Arita, Kazuko [1 ]
Hamamoto, Misuzu [1 ]
Maeda, Katsutoshi [1 ]
Oda, Hiroaki [1 ]
Doi, Shigehiro [2 ]
Masaki, Takao [2 ]
机构：
[1] Oda Med Clin, Hiroshima, Japan
[2] Hiroshima Univ Hosp, Dept OF Nephrol, Hiroshima, Japan
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2012年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：215 / 216
页数：2
相关论文
共 35 条
  • [31] Association of baseline LDL-C with total and cardiovascular mortality in patients using proprotein convertase subtilisin-kexin type 9 inhibitors: A systematic review and meta-analysis
    Khan, Safi U.
    Riaz, Haris
    Rahman, Hammad
    Khan, Muhammad U.
    Khan, Muhammad Shahzeb
    Alkhouli, Mohamad
    Kaluski, Edo
    Leucker, Thorsten M.
    Blaha, Michael J.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2019, 13 (04) : 538 - 549
  • [32] GENETIC VARIATIONS IN proprotein convertase subtilisin/kexin type 9 (PCSK9) GENE ARE ASSOCIATED WITH RESPONSE TO PEGYLATED INTERFERON/RIBAVIRIN IN HEPATITIS C VIRUS GENOTYPE 3-INFECTED PATIENTS
    Neukam, K.
    Caruz, A.
    Rivero-Juarez, A.
    Labarga, P.
    Marquez, M.
    Real, L. M.
    Herrero, R.
    Rivero, A.
    Soriano, V.
    Pineda, J. A.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S362 - S362
  • [33] Glucocorticoid Treatment in Early Rheumatoid Arthritis Is Associated with Increased Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) Levels: A Post-hoc Analysis of a Randomized Controlled Trial (NORD-STAR)
    Lend, Kristina
    Twisk, Jos W. R.
    Kumar, Nupur
    Lampa, John
    Rudin, Anna
    Hetland, Merete
    Uhlig, Till
    Nordstrom, Dan
    Ostergaard, Mikkel
    Heiberg, Marte Schrumpf
    Haavardsholm, Espen A.
    Gudbjornsson, Bjorn
    Sokka-Isler, Tuulikki
    Grondal, Gerdur Maria
    Horslev-Petersen, Kim
    Nurmohamed, Michael
    van Vollenhoven, Ronald
    Frostegard, Johan
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4225 - 4227
  • [34] Low-Density Lipoprotein Cholesterol-Lowering Effects of AMG 145, a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease in Patients With Heterozygous Familial Hypercholesterolemia The Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) Randomized Trial
    Raal, Frederick
    Scott, Rob
    Somaratne, Ransi
    Bridges, Ian
    Li, Gang
    Wasserman, Scott M.
    Stein, Evan A.
    CIRCULATION, 2012, 126 (20) : 2408 - 2417
  • [35] AMG145, a Monoclonal Antibody Against Proprotein Convertase Subtilisin Kexin Type 9, Significantly Reduces Lipoprotein(a) in Hypercholesterolemic Patients Receiving Statin Therapy: An Analysis From the LDL-C Assessment With Proprotein Convertase Subtilisin Kexin Type 9 Monoclonal Antibody Inhibition Combined With Statin Therapy (LAPLACE)-Thrombolysis in Myocardial Infarction (TIMI) 57 Trial
    Desai, Nihar R.
    Kohli, Payal
    Giugliano, Robert P.
    O'Donoghue, Michelle L.
    Somaratne, Ransi
    Zhou, Jing
    Hoffman, Elaine B.
    Huang, Fannie
    Rogers, William J.
    Wasserman, Scott M.
    Scott, Robert
    Sabatine, Marc S.
    CIRCULATION, 2013, 128 (09) : 962 - 969
1234